Paper II
2025 March (Supplementary) (2010 Scheme)

Question

Metoclopramide in vomiting.

Q81 marksShort Answers

Answer

Metoclopramide is a dopamine D2 receptor antagonist with prokinetic properties. It exerts its antiemetic effect through central D2 blockade at the chemoreceptor trigger zone (the same mechanism as other D2-antagonist antiemetics), while its additional 5-HT4 agonist/prokinetic action increases gastric emptying and lower esophageal sphincter tone — making it particularly useful for vomiting associated with delayed gastric emptying (diabetic gastroparesis, post-operative ileus) and GERD-related nausea, where a purely central antiemetic would not address the underlying motility component.

Other Years Asked


Revise MBBS
Preview